JVMAX | TCMVX | JVMAX / TCMVX | |
Total Expense Ratio | 1.12 | 0.81 | 138% |
Annual Report Gross Expense Ratio | 1.13 | 0.81 | 140% |
Fund Existence | 28 years | 23 years | - |
Gain YTD | -8.576 | -10.322 | 83% |
Front Load | 5% | 6% | 87% |
Min. Initial Investment | 1000 | 2500 | 40% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 19.6B | 1.58B | 1,243% |
Annual Yield % from dividends | 0.61 | 1.47 | 42% |
Returns for 1 year | -11.80 | -4.39 | 269% |
Returns for 3 years | -9.16 | -12.43 | 74% |
Returns for 5 years | 45.43 | 27.71 | 164% |
Returns for 10 years | 18.32 | -33.95 | -54% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
FTXH | 24.36 | 0.35 | +1.46% |
First Trust Nasdaq Pharmaceuticals ETF | |||
PGZ | 10.13 | 0.12 | +1.20% |
PRINCIPAL REAL ESTATE Income FUND | |||
PFM | 43.48 | 0.24 | +0.56% |
Invesco Dividend Achievers™ ETF | |||
ISTB | 48.22 | N/A | +0.01% |
iShares Core 1-5 Year USD Bond ETF | |||
AMZY | 14.47 | -0.45 | -3.02% |
YieldMax AMZN Option Income Strategy ETF |